116 related articles for article (PubMed ID: 11396141)
41. NTP Toxicology and Carcinogenesis Studies of 2,3-Dibromo-1-Propanol (CAS No. 96-13-9) in F344/N Rats and B6C3F1 Mice (Dermal Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Dec; 400():1-202. PubMed ID: 12563345
[TBL] [Abstract][Full Text] [Related]
42. Can surgery for cancer accelerate the progression of secondary tumors within residual minimal disease at both local and systemic levels?
Qadri SS; Wang JH; Coffey JC; Alam M; O'Donnell A; Aherne T; Redmond HP
Ann Thorac Surg; 2005 Sep; 80(3):1046-50; discussion 1050-1. PubMed ID: 16122483
[TBL] [Abstract][Full Text] [Related]
43. Toxicology and Carcinogenesis Studies of 4-Vinyl-1-cyclohexene Diepoxide (CAS No. 106-87-6) in F344/N Rats and B6C3F1 Mice (Dermal Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1989 Nov; 362():1-249. PubMed ID: 12695779
[TBL] [Abstract][Full Text] [Related]
44. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
45. Prevention of cartilage destruction with intraarticular osteoclastogenesis inhibitory factor/osteoprotegerin in a murine model of osteoarthritis.
Shimizu S; Asou Y; Itoh S; Chung UI; Kawaguchi H; Shinomiya K; Muneta T
Arthritis Rheum; 2007 Oct; 56(10):3358-65. PubMed ID: 17907189
[TBL] [Abstract][Full Text] [Related]
46. Interactions in the tumor-promoting activity of carbon tetrachloride, trichloroacetate, and dichloroacetate in the liver of male B6C3F1 mice.
Bull RJ; Sasser LB; Lei XC
Toxicology; 2004 Jul; 199(2-3):169-83. PubMed ID: 15147791
[TBL] [Abstract][Full Text] [Related]
47. The influence of shark liver oils on normal and transformed mammalian cells in culture.
Davidson BC; Rottanburg D; Prinz W; Cliff G
In Vivo; 2007; 21(2):333-7. PubMed ID: 17436585
[TBL] [Abstract][Full Text] [Related]
48. Antitumor efficacy of recombinant human interleukin-2 combined with sorafenib against mouse renal cell carcinoma.
Iguchi M; Matsumoto M; Hojo K; Wada T; Matsuo Y; Arimura A; Abe K
Jpn J Clin Oncol; 2009 May; 39(5):303-9. PubMed ID: 19336449
[TBL] [Abstract][Full Text] [Related]
49. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
50. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
Rodins K; Cheale M; Coleman N; Fox SB
Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
[TBL] [Abstract][Full Text] [Related]
51. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
[TBL] [Abstract][Full Text] [Related]
52. NTP Toxicology and Carcinogenesis Studies of Benzene (CAS No. 71-43-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1986 Apr; 289():1-277. PubMed ID: 12748714
[TBL] [Abstract][Full Text] [Related]
53. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
54. Effect of chemopreventive agents on separate stages of progression of benzo[alpha]pyrene induced lung tumors in A/J mice.
Estensen RD; Jordan MM; Wiedmann TS; Galbraith AR; Steele VE; Wattenberg LW
Carcinogenesis; 2004 Feb; 25(2):197-201. PubMed ID: 14578161
[TBL] [Abstract][Full Text] [Related]
55. [Molecular changes in development and progression of urothelial carcinoma].
Hartmann A
Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
[TBL] [Abstract][Full Text] [Related]
56. Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma.
Ratain MJ; Eisen T; Stadler WM; Flaherty KT; Kaye SB; Rosner GL; Gore M; Desai AA; Patnaik A; Xiong HQ; Rowinsky E; Abbruzzese JL; Xia C; Simantov R; Schwartz B; O'Dwyer PJ
J Clin Oncol; 2006 Jun; 24(16):2505-12. PubMed ID: 16636341
[TBL] [Abstract][Full Text] [Related]
57. NTP Toxicology and Carcinogenesis Studies of Rotenone (CAS No. 83-79-4) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1988 Jan; 320():1-158. PubMed ID: 12748733
[TBL] [Abstract][Full Text] [Related]
58. NTP Toxicology and Carcinogenesis Studies of Methyl Carbamate (CAS No. 598-55-0) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1987 Nov; 328():1-176. PubMed ID: 12732908
[TBL] [Abstract][Full Text] [Related]
59. Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice.
Yang X; Edgerton SM; Kosanke SD; Mason TL; Alvarez KM; Liu N; Chatterton RT; Liu B; Wang Q; Kim A; Murthy S; Thor AD
Cancer Res; 2003 May; 63(10):2425-33. PubMed ID: 12750262
[TBL] [Abstract][Full Text] [Related]
60. Etiology of bromate-induced cancer and possible modes of action-studies in Japan.
Umemura T; Kurokawa Y
Toxicology; 2006 Apr; 221(2-3):154-7. PubMed ID: 16473452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
